Insilico Joins Scramble to Treat Solid Tumors by Targeting KIF18A GEN, 20 Feb 2024 Alex Zhavoronkov, PhD, Insilico’s founder, chairman, and CEO Insilico Medicine is entering the fast-growing scramble among drug…